National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Prostate Cancer Prevention (PDQ®)     
Last Modified: 07/27/2009
Health Professional Version
Changes To This Summary (07/27/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Summary of Evidence 1

Added text 2 about the Selenium and Vitamin E Cancer Prevention Trial, which failed to demonstrate that vitamin E and selenium reduce prostate cancer period prevalence (cited Lippman et al. as reference 2).

Significance 3

Updated incidence and mortality estimates 4 for 2009 (cited American Cancer Society as reference 1).

Risk Factors for Prostate Cancer Development 5

Added text 6 about the Aspirin/Folate Polyp Prevention Study, a placebo-controlled randomized trial of aspirin and folic acid supplementation for the chemoprevention of colorectal adenomas (cited Figueiredo et al. as reference 44 and Kristal et al. as reference 45).



Table of Links

1http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/1
.cdr#Section_1
2http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/2
09.cdr#Section_209
3http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/9
.cdr#Section_9
4http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/1
1.cdr#Section_11
5http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/1
7.cdr#Section_17
6http://www.cancer.gov/cancertopics/pdq/prevention/prostate/healthprofessional/2
15.cdr#Section_215